Skip to main content
RE

Release Therapeutics

Geneva, Switzerland
Last funding
$3.9M
SeedAug 2024

Release Therapeutics is a private BioMedTech company on a mission to treat genetic diseases of the CNS without gene therapy.

About Release Therapeutics

How much funding has Release Therapeutics raised?

Release Therapeutics has raised $3.9M in total funding. The most recent round was Seed. The last funding was announced in August 2024.

Where is Release Therapeutics headquartered?

Release Therapeutics is headquartered in Geneva, Switzerland.

What does Release Therapeutics do?

Release Therapeutics is a private BioMedTech company on a mission to treat genetic diseases of the CNS without gene therapy.

What stage is Release Therapeutics at?

Release Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Release Therapeutics — Funding & Investors." VCBacked, August 6, 2024, https://www.vcbacked.co/company/release-therapeutics. Accessed November 20, 2026.
APA
VCBacked. (2024). Release Therapeutics — Funding & Investors. Retrieved November 20, 2026, from https://www.vcbacked.co/company/release-therapeutics
Wikipedia (cite web)
{{cite web |title=Release Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/release-therapeutics |website=VCBacked |access-date=November 20, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Release Therapeutics? Request a listing update

Founder contacts
m***@release-tx.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →